Tags

Type your tag names separated by a space and hit enter

Of chloroquine and COVID-19.
Antiviral Res. 2020 05; 177:104762.AR

Abstract

Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.

Authors+Show Affiliations

Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France. Electronic address: franck.touret@univ-amu.fr.Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France. Electronic address: xavier.de-lamballerie@univ-amu.fr.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32147496

Citation

Touret, Franck, and Xavier de Lamballerie. "Of Chloroquine and COVID-19." Antiviral Research, vol. 177, 2020, p. 104762.
Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antiviral Res. 2020;177:104762.
Touret, F., & de Lamballerie, X. (2020). Of chloroquine and COVID-19. Antiviral Research, 177, 104762. https://doi.org/10.1016/j.antiviral.2020.104762
Touret F, de Lamballerie X. Of Chloroquine and COVID-19. Antiviral Res. 2020;177:104762. PubMed PMID: 32147496.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Of chloroquine and COVID-19. AU - Touret,Franck, AU - de Lamballerie,Xavier, Y1 - 2020/03/05/ PY - 2020/02/29/received PY - 2020/03/02/revised PY - 2020/03/02/accepted PY - 2020/3/10/pubmed PY - 2020/4/24/medline PY - 2020/3/10/entrez KW - 2019-nCoV KW - Antiviral KW - COVID-19 KW - Chloroquine KW - SARS-CoV-2 SP - 104762 EP - 104762 JF - Antiviral research JO - Antiviral Res VL - 177 N2 - Recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research. SN - 1872-9096 UR - https://www.unboundmedicine.com/medline/citation/32147496/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S0166-3542(20)30114-5 DB - PRIME DP - Unbound Medicine ER -